5.39% -0.13

Cytomx Therapeutics Inc (CTMX)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Cytomx Therapeutics Inc Azioni (CTMX) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	86.18% 1.418	10.26	0.663	5.963	18.66
Operating Expenses	15.81% 25.20	29.93	28.59	21.73	19.94
Operating Income/Loss	20.89% -23.78	-19.67	-27.93	-15.77	-1.286
Income/Loss From Continuing Operations Before Tax	13.29% -20.61	-18.19	-26.46	-14.17	-0.091
Income Tax Expense/Benefit	1.69% 0.06	0.059	0.054	0.058	0.063
Net Income/Loss	13.25% -20.67	-18.25	-26.51	-14.23	-0.154
Basic Average Shares	23.50% 218.94	177.27	-	165.00	129.08
Diluted Average Shares	23.50% 218.94	177.27	-	165.00	129.08

OLMA

$6.58

4.22%

ZVRA

$9.94

3.21%

SLDB

$5.53

3.66%

AVTX

$11.27

6.16%

NVCT

$18.60

1.74%

WVE

$3.13

1.88%